Obtaining high yields of viable engineered T cells for cell therapy research and immunotherapy development can be challenging. Lengthy and inefficient processes for cell isolation, cell culture, and gene transfer can cause delays and prevent scientists from reaching their goals. Watch as Drs. Sneha Balani and Angela Zhang discuss best practices and innovative technologies for T cell therapy research.

This webinar consists of two presentations:
1. Tools & Reagents to Stay Ahead of the Competition – Dr. Balani, Product Manager, STEMCELL Technologies
Learn how to fully optimize your workflow when obtaining T cells—from cell sourcing and isolation, to cell culture and beyond.

Topics covered:

• - How to efficiently isolate T cells
• - How to culture, activate, and expand T cells
• - How to generate T cells from cord blood and pluripotent stem cells

2. Rethink T Cell Therapy with Lipid Nanoparticles – Dr. Zhang, Senior Product Manager, Precision NanoSystems
Advance your T cell therapy research with a new lipid nanoparticle reagent mix that enables cell therapy researchers to establish a clinically-relevant method for ex vivo gene delivery.

Topics covered:

• - Challenges with current ex vivo gene delivery strategies for cell therapies
• - Introduction of GenVoy lipid nanoparticle delivery platform
• - Proof-of-concept discovery work performed using GenVoy-ILM T Cell Kit for mRNA